CYBERJAYA: The waiting period for cancer patients receiving treatment depends on several factors, including the urgency, says Health Minister Datuk Seri Dr Dzulkefly Ahmad.
In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisation in healthcare by introducing Artificial Intelligence (AI) x-ray technology into early lung screening at government clinics and hospitals under the Projek Saringan Awal Paru-Paru (SAPU) programme. As a centre of excellence for cancer care in the country, IKN will be the first government institution in the country to implement this AI technology.
AI will help Institut Kanser Negara (IKN) to help screen for early stages of lung cancer in Malaysia, thanks to a recent collaboration announcement with AstraZeneca